Morgan Stanley’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Sell |
8,840
-23,040
| -72% | -$96.3K | ﹤0.01% | 6455 |
|
|
2025
Q1 | $50.7K | Sell |
31,880
-29,146
| -48% | -$46.3K | ﹤0.01% | 6262 |
|
|
2024
Q4 | $173K | Buy |
61,026
+3,634
| +6% | +$10.3K | ﹤0.01% | 5844 |
|
|
2024
Q3 | $224K | Buy |
57,392
+35,920
| +167% | +$140K | ﹤0.01% | 5715 |
|
|
2024
Q2 | $172K | Buy |
+21,472
| New | +$172K | ﹤0.01% | 5745 |
|